Your browser doesn't support javascript.
loading
In silico design of two novel fusion proteins, p28-IL-24 and p28-M4, targeted to breast cancer cells.
Ghavimi, Reza; Mohammadi, Elmira; Akbari, Vajihe; Shafiee, Fatemeh; Jahanian-Najafabadi, Ali.
Afiliação
  • Ghavimi R; Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.
  • Mohammadi E; Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.
  • Akbari V; Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.
  • Shafiee F; Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.
  • Jahanian-Najafabadi A; Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.
Res Pharm Sci ; 15(2): 200-208, 2020 Apr.
Article em En | MEDLINE | ID: mdl-32582360
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Res Pharm Sci Ano de publicação: 2020 Tipo de documento: Article País de publicação: Irã
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Res Pharm Sci Ano de publicação: 2020 Tipo de documento: Article País de publicação: Irã